Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer

ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial

(2013) J E Bauman et al.   BRITISH JOURNAL OF CANCER

ERCC1 Protein Expression Is Associated with Differential Survival in Oropharyngeal Head and Neck Squamous Cell Carcinoma

(2013) Mihir R. Patel et al.   OTOLARYNGOLOGY-HEAD AND NECK SURGERY

DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells

(2013) Sanne R. Martens-de Kemp et al.   PLoS One

Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma

(2012) Alexandra Fullár et al.   EXPERIMENTAL CELL RESEARCH

Role of excision repair cross-complementation 1 expression as a prognostic marker for response to radiotherapy in early-stage laryngeal cancer

(2012) Kimberly Johung et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherapy

(2012) Vesna Bišof et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Neuroendocrine differentiation in head and neck squamous cell carcinoma

(2012) V H Schartinger et al.   JOURNAL OF LARYNGOLOGY AND OTOLOGY

Co-overexpression of Bag-1 and heat shock protein 70 in human epidermal squamous cell carcinoma: Bag-1-mediated resistance to 5-fluorouracil-induced apoptosis

(2011) J Wood et al.   BRITISH JOURNAL OF CANCER

XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck

(2011) Alec Vaezi et al.   CLINICAL CANCER RESEARCH

The knock-down of ERCC1 but not of XPF causes multinucleation

(2011) Julie Rageul et al.   DNA REPAIR

Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblasts

(2011) József Dudás et al.   EXPERIMENTAL CELL RESEARCH

High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area

(2011) Tai-Jan Chiu et al.   Journal of Translational Medicine

Differential responses of fibroblasts, non-neoplastic epithelial cells, and oral carcinoma cells to low-level laser therapy

(2011) Volker Hans Schartinger et al.   SUPPORTIVE CARE IN CANCER

Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells

(2010) József Dudás et al.   ORAL ONCOLOGY

Class III  -tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma

(2009) Y. Koh et al.   ANNALS OF ONCOLOGY

Immunodetection of DNA Repair Endonuclease ERCC1-XPF in Human Tissue

(2009) N. R. Bhagwat et al.   CANCER RESEARCH

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

(2009) Stefan Michiels et al.   LANCET ONCOLOGY

XPF-ERCC1 Participates in the Fanconi Anemia Pathway of Cross-Link Repair

(2009) N. Bhagwat et al.   MOLECULAR AND CELLULAR BIOLOGY

Altered regulation of Prox1-gene-expression in liver tumors

(2008) Jozsef Dudas et al.   BMC CANCER

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

(2008) H J Jun et al.   BRITISH JOURNAL OF CANCER

Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury

(2008) Jozsef Dudas et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Chemotherapy in the treatment of locally advanced head and neck cancer

(2008) Arlene A. Forastiere   JOURNAL OF SURGICAL ONCOLOGY

The role of dihydropyrimidine dehydrogenase expression in resistance to 5-fluorouracil in head and neck squamous cell carcinoma cells

(2008) Ryuji Yasumatsu et al.   ORAL ONCOLOGY

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines

(2008) Junichi SHIMIZU et al.   RESPIROLOGY